Endothelial Injury-Induced Shedding of Thrombomodulin as a Biomarker for Predicting Adverse Prognosis in Sepsis

Xinmeichen Meng1, Xuemei Chen1, Jiwen Liu2

  • 1Postgraduate Training Base at Shanghai Gongli Hospital, Ningxia Medical University, Shanghai, 200135, People's Republic of China.

PubMed
Abstract

Insights

Plasma thrombomodulin (TM) levels, combined with the CD64 index, effectively predict sepsis severity and patient outcomes. This finding highlights endothelial injury as a key mechanism in sepsis progression.

Area of Science:

  • Biomarker discovery
  • Sepsis research
  • Endothelial biology

Background:

  • Sepsis-induced endothelial injury leads to thrombomodulin (TM) shedding and coagulopathy.
  • Plasma TM levels are hypothesized to predict sepsis severity and prognosis.

Purpose of the Study:

  • To investigate the prognostic association of plasma TM as a sepsis biomarker.
  • To validate TM's prognostic value in a murine model.

Main Methods:

  • Prospective cohort study of 68 sepsis patients and 50 controls.
  • Assessed plasma TM, CD64 index, PCT, CRP, SOFA, and APACHE II scores.
  • Utilized survival analysis, regression, ROC modeling, and a murine sepsis model (CLP).

Main Results:

  • Elevated plasma TM and CD64 index correlated with poor prognosis (p<0.05).
  • Combined TM/CD64 Index ROC model showed superior predictive performance (AUC=0.9671) versus individual markers.
  • TM levels positively correlated with SOFA and APACHE II scores; plasma TM increased while aortic TM decreased in vivo.

Conclusions:

  • Combined plasma TM and CD64 index assessment improves early prediction of adverse sepsis outcomes.
  • Paradoxical TM dynamics suggest endothelial injury as a key sepsis mechanism.
  • Further multicenter validation and mechanistic studies are needed for clinical translation.

Related Concept Videos

Introduction to Hemostasis01:05

Introduction to Hemostasis

Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
14.2K
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
6.2K
Coagulation01:09

Coagulation

The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
8.4K
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
10.9K
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
1.2K
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
765